Skip to main content

Animations

MJFF Publications

3211 - 3220 of 8571 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2022
  • 2019
  • 2013
  • 2025
  • 2017
  • 2016
  • 2019
  • 2016
  • Summary Details
    OPEN
    Title: Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.765321
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Closing the structure-to-function gap for LRRK2
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 44
  • Summary Details
    RESTRICTED
    Title: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1037/neu0000503
    Best OA location URL:
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s disease
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025
    Citation Count: 28
  • Summary Details
    OPEN
    Title: LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf103
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brain
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.019
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1523708113
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27818
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Nucleolar PARP-1 Expression Is Decreased in Alzheimer’s Disease: Consequences for Epigenetic Regulation of rDNA and Cognition
    Journal Name: Neural Plasticity
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2016/8987928
    Citation Count: 49
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.